Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

646 articles

Research Review

Showing 1–1 of 1 articles · Keyword: Cloud MAX technology Clear keyword

International journal of pharmaceutics: X2026ResearchNon-viral Gene DeliveryDrug Delivery

1. Microliter-scale in vitro aerosol-cell delivery of inhalable antisense oligonucleotide (ASO) induces "burst-like" pharmacokinetics

Kumar P, Chakraborty A, Richter E, Yang L, Schröppel A, Mergault C, Et Al.

Unlike traditional submerged cell cultures, nebulized drug delivery to air-liquid interface (ALI)-cultured lung cells provides a clinically relevant route for in vitro testing of inhalable drugs. Current nebulizer systems deliver non-physiologically large drug volumes. Here, we introduce the Cloud MAX technology…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.